Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Quinolin 2(1H)one. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN114478375A details a novel Pd-catalyzed reductive aminocarbonylation route. This method offers significant cost reduction in API manufacturing and enhanced supply chain reliability.
Patent CN113045489B details a novel Pd-catalyzed route to 3-arylquinolin-2(1H)ones using benzisoxazole, offering cost reduction in API manufacturing and scalable production.
Patent CN114478375A details a novel Pd-catalyzed route to quinolin-2(1H)ones using o-nitrobenzaldehyde, offering cost reduction in API manufacturing and scalable supply.
Patent CN113045489B details a novel Pd-catalyzed route for quinolin-2(1H)ones, offering cost-effective API intermediate manufacturing with high functional group tolerance.
Patent CN114478375A reveals a novel Pd-catalyzed route to 3-alkenyl quinolin-2(1H)ones using allyl aryl ethers, offering safer carbonylation and cost reduction in API manufacturing.
Patent CN113045489B details a novel Pd-catalyzed route to 3-arylquinolin-2(1H)ones using benzisoxazole, offering significant cost reduction in API manufacturing and enhanced supply chain reliability.
Novel Pd-catalyzed carbonylation method using benzisoxazole offers high yields and simplified purification for pharmaceutical intermediates.
Patent CN113045489A reveals a novel Pd-catalyzed aminocarbonylation route for high-purity API intermediates, offering significant cost reduction and scalable manufacturing.
Patent CN113045489B details a novel Pd-catalyzed route to 3-arylquinolin-2(1H)ones using benzisoxazole, offering significant cost reduction and supply chain reliability for API manufacturing.
Patent CN114478375A reveals a novel Pd-catalyzed route for 3-alkenyl quinolin-2(1H)ones, offering significant cost reduction in fine chemical manufacturing and enhanced supply chain reliability.
Patent CN113045489B details a novel Pd-catalyzed aminocarbonylation route for 3-arylquinolin-2(1H)ones, offering significant cost reduction in API manufacturing and scalable supply chain solutions.
Patent CN114478375A details a novel Pd-catalyzed route to 3-alkenyl quinolin-2(1H)ones, offering reliable pharmaceutical intermediate supply with simplified operations.
Patent CN113045489B details a novel Pd-catalyzed route to 3-arylquinolin-2(1H)ones using benzisoxazole, offering significant cost reduction and supply chain reliability for API intermediates.
Patent CN113045489B details a novel Pd-catalyzed carbonylation route using benzisoxazole, offering cost-effective synthesis for pharmaceutical intermediates.
Patent CN113045489B details a novel Pd-catalyzed aminocarbonylation route for 3-arylquinolin-2(1H)one derivatives, offering cost reduction in API manufacturing and scalable supply chain solutions.
Novel Pd-catalyzed method for 3-arylquinolin-2(1H)ones using benzisoxazole. High yield, scalable process for pharmaceutical intermediates.
Patent CN113045489B details a novel Pd-catalyzed route to 3-arylquinolin-2(1H)ones using benzisoxazole, offering high yields and simplified supply chains for API intermediates.
Patent CN113045489B details a novel Pd-catalyzed route for quinolinone derivatives, offering cost reduction in API manufacturing and reliable supply chain solutions.
Advanced Pd-catalyzed carbonylation patent CN113045489B enables cost-effective manufacturing of high-purity pharmaceutical intermediates with scalable processes.
Patent CN113045489B details a novel Pd-catalyzed route to quinolinones using benzisoxazole, offering significant cost reduction in API manufacturing and scalable supply.